A 2024 UK study found a life expectancy of 13.2 years from a sample of 47 deaths for the breed compared to an average of 12.7 for purebreeds and 12 for
crossbreeds. Tollers are generally hardy. However, like almost all dog breeds, certain genetic disorders are known to occur in the breed. This is sometimes blamed on a relatively small gene pool. The Finnish breed club states the largest health problems in the breed tend to be immunity related.
Progressive retinal atrophy (PRA) affects about 7% of Tollers with an estimated 40% being carriers. The type of PRA associated with the breed is known as progressive rod-cone degeneration. The disease causes cells in the retina to degenerate and die. This causes night blindness at first and eventually complete blindness.
Collie eye anomaly is estimated to have a carrier rate of 5% and an affected rate of 0.5%. It generally only causes mildly impaired vision, although in more severe cases it can lead to retinal hemorrhaging and detachments resulting in blindness. Thyroid problems have been identified by American breeders as a priority issue, together with epilepsy and hip dysplasia. As many as 1 in 6 Tollers may have
autoimmune thyroiditis. Symptoms of thyroid problems includes weight gain, skin and hair problems including hair loss, weakness, cold intolerance or infertility.
Addison's disease affected 1% of Tollers in a health survey, an incidence rate 10 times more than the general dog population. Carrier rate is estimated at 18%. This disease is also considered an important issue in the breed. Signs include lethargy, decreased appetite, vomiting, weakness, diarrhea, increased drinking and urination, and shivering.
Aseptic meningitis (sometimes called steroid-responsive meningitis) has been diagnosed in increasing numbers in the Norwegian Toller population in recent years. Symptoms include intensive neck pain, fever, and lethargy. Prevalence is estimated at 2.5% in the Norwegian population. Health tests are available for both eye diseases and autoimmune thyroiditis. A test for Addison's disease is available but it is only for one form of the disease and there are other forms which also affect the breed. A test is also available for one form of
cleft palate that is exclusive to Tollers. Early testing shows a carrier rate of about 15%. A survey conducted in 2002 by the Canadian Nova Scotia Duck Tolling Retriever breed club to discover which diseases and conditions occur in the Toller population, involving owners of 1180 dogs worldwide, showed 73% reported in excellent health and a total of 7.5% reporting poor or bad health. 141 dogs (12%) were reported as deceased with the average age at death being 6.4 years. The most common cause of death was cancer, reported in 25% of deaths, with old age being the next most common at 9%. A worldwide study of the Tollers' registration history in 17 countries shows that about 90% of the genetic diversity present in the founding population has been lost. Tollers born between 1999 and 2008 have an effective founder size of 9.8, realized effective
population size of 18 and an average
inbreeding coefficient of 0.26. Breeders are working to prevent
losing heterozygosity and to maintain sufficient genetic variations. High
kinship value means the breed is not able to maintain a steady level of inbreeding in the long term. == Activities ==